These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Can patient selection for bladder preservation be based on response to chemotherapy? Sternberg CN; Pansadoro V; CalabrĂ² F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521 [TBL] [Abstract][Full Text] [Related]
5. Two cases of plasmacytoid variant of urothelial carcinoma of urinary bladder: systemic chemotherapy might be of benefit. Hayashi T; Tanigawa G; Fujita K; Imamura R; Nakazawa S; Yamamoto Y; Hosomi M; Shimazu K; Fushimi H; Yamaguchi S Int J Clin Oncol; 2011 Dec; 16(6):759-62. PubMed ID: 21732230 [TBL] [Abstract][Full Text] [Related]
6. Mixed micropapillary and trophoblastic carcinoma of bladder: report of a first case with new immunohistochemical evidence of urothelial origin. Regalado JJ Hum Pathol; 2004 Mar; 35(3):382-4. PubMed ID: 15017598 [TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer. Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
10. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer. Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396 [TBL] [Abstract][Full Text] [Related]
11. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Soga N; Arima K; Sugimura Y Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862 [TBL] [Abstract][Full Text] [Related]
13. [Annular rectal constriction caused by infiltrating bladder carcinoma: a case report]. Katayama H; Mituzuka K; Kawasaki Y; Kato S Hinyokika Kiyo; 2010 Apr; 56(4):229-31. PubMed ID: 20448448 [TBL] [Abstract][Full Text] [Related]
14. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy]. Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. Herr HW; Scher HI Cancer Treat Res; 1992; 59():99-103. PubMed ID: 1347698 [No Abstract] [Full Text] [Related]
16. Plasmacytoid urothelial carcinoma of the bladder. Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884 [TBL] [Abstract][Full Text] [Related]
17. Malignant urothelial carcinoma of urinary bladder in a young child: a rare case report. Neogi S; Kariholu PL; Dhakre G; Gupta V; Agarwal N; Bhadani P Urology; 2013 Apr; 81(4):888-90. PubMed ID: 23394879 [TBL] [Abstract][Full Text] [Related]
18. Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma. Viens P; Gravis G; Bladou F; Lechevallier E; Baume D; Camerlo J; Cowen D; Coulange C; Serment G; Resbeut M; Maraninchi D Eur Cytokine Netw; 1996 Sep; 7(3):395-9. PubMed ID: 8954183 [TBL] [Abstract][Full Text] [Related]
19. Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9. Shimada K; Nakamura M; Ishida E; Konishi N Urology; 2006 Oct; 68(4):891.e7-10. PubMed ID: 17070387 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder. Simon SD; Srougi M Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415 [No Abstract] [Full Text] [Related] [Next] [New Search]